ISRCTN84852151进行中（未招募）Unknown
Mixed method, two level, individually randomised controlled trial of a trauma informed intervention, Trauma Recovery Model Relationship Building Together, versus business as usual for adolescents and young adults served by Bridgend Youth Services
niversity of Kent0 个研究点目标入组 562 人开始时间: 2024年3月8日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 562
研究概览
简要总结
2024 Protocol article in https://youthendowmentfund.org.uk/wp-content/uploads/2024/01/Bridgend-Youth-Services-Protocol-Jan-2024.pdf (added 14/02/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 10-21 years old
- •2. Referred for assessment at participating service
- •3. Willing and able to provide informed consent
排除标准
- •Not meeting the inclusion criteria
研究者
相似试验
已完成
3 期
Protocol Title: A prospective, randomized, doubleblind, placebo controlled, parallel groupstudy to evaluate the safety and efficacy of Dose for your Liver (Dietary Supplement) onLiver function and other associated health markers in healthy volunteers.CTRI/2023/06/054492EETHO BRANDS INC130
已完成
2 期
Assessing Immune Response of Different COVID-19 Vaccines in Older AdultsNCT05160766Oliver Cornely, MD323
已完成
不适用
Novel Approaches for Quantitative Assessment of AdherenceHealthyNCT04535934University of Colorado, Denver15
进行中（未招募）
1 期
Estudio fase II, aleatorizado, doble ciego, multicéntrico de búsqueda de dosis que evalúa la eficacia y seguridad del profármaco inhibidor de la polimerasa VHC (RO4588161) cuando se asocia con Pegasys® y Copegus® comparado con la asociación actualmente aprobada de Pegasys® y Copegus® en el tratamiento de pacientes sin tratamiento previo con infección por el virus de la hepatitis C crónica genotipo 1A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys® and Copegus® versus the currently approved combination of Pegasys® and Copegus® in Treatment-Naive Patients with Chronic Hepatitis C Genotype 1 Virus infectioHepatitis C CrónicaChronic hepatitis CMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2006-006604-11-ESF. Hoffmann-La Roche Ltd490
已完成
2 期
A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBCBreast CancerNCT03394287Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University40